背景:本研究旨在阐明脾切除术中LigaSure技术和常规技术的最佳管理。
方法:所有数据库,包括CBM,CNKI,WFPD,Medline,EMBASE,PubMed,和截至2023年4月的Cochrane数据库进行了搜索,以比较LigaSure技术与常规技术的相关研究。六项研究,由两名独立审稿人摘录,进行失血评估,手术时间,转换,死亡率,住院,和输血。
结果:常规组的失血量明显高于LigaSure组(WMD=-48.98,95%CI:-62.41至-35.55,P<.00001)。同时,LigaSure组的平均手术时间明显短于常规组(WMD=-10.57;95%CI:-12.35至-8.78),P<.00001)。在转化率方面没有发现显著差异,住院,发病率,和输血。
结论:LigaSure技术具有与常规技术相当的效果,但在一定程度上减少了失血量和手术时间.
BACKGROUND: This study aimed to clarify the optimal management of the LigaSure technique and conventional techniques during splenectomy.
METHODS: All databases, including CBM, CNKI, WFPD,
Medline, EMBASE, PubMed, and Cochrane databases up to April 2023, were searched for relevant studies comparing the LigaSure technique with conventional techniques. Six studies, extracted by 2 independent reviewers, were evaluated for blood loss, operative time, conversion, mortality, hospital stay, and transfusion.
RESULTS: The blood loss was significantly higher in the convention group than in the LigaSure group (WMD = -48.98, 95% CI: -62.41 to -35.55, P < .00001). Meanwhile, the mean operative time was significantly shorter in LigaSure group than in convention group (WMD = -10.57; 95% CI: -12.35 to -8.78), P < .00001). No significant differences were found regarding the conversion rate, hospital stay, morbidity, and transfusion.
CONCLUSIONS: The LigaSure technique has comparable effects to conventional techniques, but to some extent reduces blood loss and operative time.